Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
в найденном
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Отсортировать найденные документы по:
авторузаглавиюгоду изданиятипу документа
Поисковый запрос: (<.>S=КОМБИНИРОВАННАЯ ТЕРАПИЯ<.>)
Общее количество найденных документов : 479
Показаны документы с 1 по 20
 1-20    21-40   41-60   61-80   81-100   101-120      
1.
A chitosan hydrogel delivery system for osteosarcoma gene therapy with pigment epithelium-derived factor combined with chemotherapy // Biomaterials, 2009. Vol. 30, N 27.-С.4815-4823

2.
A gene nanocomplex conjugated with monoclonal antibodies for targeted therapy of hepatocellular carcinoma // Biomaterials, 2012. Vol. 33, N 18.-С.4597-4607

3.
A gene nanocomplex conjugated with monoclonal antibodies for targeted therapy of hepatocellular carcinoma // Biomaterials, 2012. Vol. 33, N 18.-С.4597-4607

4.
A glimmer of hope // New Sci., 1996. Vol. 151, N 2039.-С.3

5.
A glimmer of hope // New Sci., 1996. Vol. 151, N 2039.-С.3

6.
A polymer-protein core-shell nanomedicine for inhibiting cancer migration followed by photo-triggered killing // J. Biomed. Nanotechnol., 2014. Vol. 10, N 8.-С.1401-1415

7.
A polymer-protein core-shell nanomedicine for inhibiting cancer migration followed by photo-triggered killing // J. Biomed. Nanotechnol., 2014. Vol. 10, N 8.-С.1401-1415

8.
A polymer-protein core-shell nanomedicine for inhibiting cancer migration followed by photo-triggered killing // J. Biomed. Nanotechnol., 2014. Vol. 10, N 8.-С.1401-1415

9.
Adalimumab or cyclosporine as monotherapy and in combination in severe psoriatic arthritis. Results from a prospective 12-month nonrandomized unblinded clinical trial // J. Rheumatol., 2011. Vol. 38, N 11.-С.2466-2474

10.
Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitro // Int. J. Cancer, 2005. Vol. 115, N 4.-С.630-640

11.
Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitro // Int. J. Cancer, 2005. Vol. 115, N 4.-С.630-640

12.
Adefovir-based combination therapy with entecavir or lamivudine for patients with entecavir-refractory chronic hepatitis B // J. Med. Virol., 2012. Vol. 84, N 1.-С.18-25

13.
Adefovir-based combination therapy with entecavir or lamivudine for patients with entecavir-refractory chronic hepatitis B // J. Med. Virol., 2012. Vol. 84, N 1.-С.18-25

14.
Akela SIDA: les molcules de l'espoir // Sci. et avenir., 1993, Hors ser. N91.-С.48-49

15.
Amphiphilic methoxy poly(ethylene glycol)-b-poly('эпсилон'-caprolactone)-b-poly(2-dimethylaminoethyl) methacrylate cationic copolymer nanoparticles as a vector for gene and drug delivery // Biomacromolecules, 2010. Vol. 11, N 9.-С.2306-2312

16.
An alternative to hysterectomy? GnRH analogue combined with hormone replacement therapy // Brit. J. Obstet. and Gynaecol., 1993. Vol. 100, N 4.-С.360-364

17.
An early viral response to standard interferon-alpha identifies resistance to combination therapy with peginterferon and ribavirin in patients infected by HCV genotype 1 // J. Med. Virol., 2010. Vol. 82, N 9.-С.1537-1544

18.
An early viral response to standard interferon-alpha identifies resistance to combination therapy with peginterferon and ribavirin in patients infected by HCV genotype 1 // J. Med. Virol., 2010. Vol. 82, N 9.-С.1537-1544

19.
Analysis of anticonvulsant and neurotoxic responses to combination therapy with carbamazepine, felbamate and phenytoin by response-surface modeling // Arzneim.-Forsch., 1995. Vol. 45, N 7.-С.739-748

20.
Andreopoulou Management of postmenopausal osteoporosis // Annual Review of Medicine. -Palo Alto (Calif.), 2015. 2015, Vol. 66.-С.329-342

 1-20    21-40   41-60   61-80   81-100   101-120      
 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)